The Relation between Obesity and Glomerular Filtration Rate in Children and Adolescents

소아 및 청소년에서 비만과 사구체여과율과의 관계

  • Jung, Youngsu (Department of Pediatrics, College of Medicine, Chungang University) ;
  • Kim, Dongwoon (Department of Pediatrics, College of Medicine, Chungang University) ;
  • Lim, Inseok (Department of Pediatrics, College of Medicine, Chungang University)
  • 정영수 (중앙대학교 의과대학 소아과학교실) ;
  • 김동운 (중앙대학교 의과대학 소아과학교실) ;
  • 임인석 (중앙대학교 의과대학 소아과학교실)
  • Received : 2005.08.01
  • Accepted : 2005.08.26
  • Published : 2005.11.15

Abstract

Purpose : The prevalence of obesity in children and adolescents has been rising rapidly in Korea because of changes of diet and lifestyle. As with adults, obesity in children and adolescents can cause diabetes mellitus, hyperlipidemia, cardiovascular diseases and renal diseases. The aim of the present study is to examine the relation of obesity, glomerular filtration rate(GFR) and serum cystatin C concentration in children and adolescents. Methods : Data of 115 children and adolescents aged between 6 years and 20 years without clinical evidence of renal diseases were included in the study. From May 2004 to December 2004, blood samples were collected from children and adolescents who were seen at the Department of Pediatrics at Chungang University Yongsan Hospital. Obesity degrees and body mass indices(BMI) were measured, and GFRs were estimated from Schwartz's formula. Serum cystatin C was measured by particle enhanced nephelometric immunoassay using Behring Nephelometer II. Results : GFRs were significantly different between the obese group(BMI >95 percentile, $145.79{\pm}23.10mL/min$) and the non-obese group(BMI <95 percentile, $134.61{\pm}26.19mL/min$) divided by BMI (P=0.031). GFRs were not significantly different between the obese group(obesity degree >120 percent, $144.29{\pm}23.08mL/min$) and the non-obese group(obesity degree <120 percent, $134.54{\pm}26.57mL/min$) divided by obesity degree(P=0.051), but were significantly different between severe obese group (obesity degree >150 percent, $155.55{\pm}20.40mL/min$) and the non-obese group(P=0.004). GFRs were correlated positively with BMI($r^2=0.037$, P=0.039), but were not correlated significantly with obesity degree($r^2=0.030$, P=0.066). Serum cystatin C concentrations were not significantly different between the obese group and the non-obese group, divided by BMI as well as by obesity degree(P>0.05). Conclusion : Obesity may lead to an alteration of renal hemodynamics such as hyperfiltration, appropriate control and management for obesity is necessary.

목 적 : 최근 소아 및 청소년의 비만이 빠르게 증가하고 있다. 고도 비만아들에서 단백뇨 및 FSGS가 발현될 수 있고, 그 기전으로 과여과, 신정맥압 증가, 사구체비대, 고지혈증, angiotensin II, insulin, leptin, $TGF-{\beta}1$의 합성 증가 등이 보고되고 있다. 본 연구에서는 BMI와 비만도에 따른 GFR의 변화를 조사하여 과여과 여부를 알아보았고, 혈청 cystatin C 농도를 측정하여 비만과의 상관관계와 유용성을 알아보고자 하였다. 방 법 : 2004년 5월부터 12월까지 중앙대학교 용산병원을 방문하여 혈액검사를 시행받은 6세 이상의 환아들 중에서 임상적으로나 검사상으로 명백한 신질환의 증거가 없는 115명의 환아들을 대상으로 BMI와 비만도를 측정하였고, Schwartz's formula로 GFR을 추정하였다. 혈청 cystatin C 농도는 particle enhanced nephelometric immunoassay를 이용하여 Behring Nephelometer II로 측정하였다. 결 과 : GFR은 BMI로 구분한 경우 비만군이 정상군에 비해 유의하게 높았다. GFR은 비만도로 구분한 경우에는 비만군과 정상군 사이에 유의한 차이를 보이지 않았지만 고도 비만군은 정상군에 비해 유의하게 높은 값을 나타내었다. BMI와 GFR은 양의 상관관계를 보였으나, 비만도와 GFR은 유의한 상관관계를 보이지 않았다. 혈청 cystatin C 농도는 BMI로 구분한 경우와 비만도로 구분한 경우 모두 비만군과 정상군 사이에 유의한 차이를 보이지 않았고, BMI나 비만도와 통계학적으로 유의한 상관관계를 나타내지 않았다. 결 론 : 비만으로 인해 과여과와 같은 신기능의 변화가 초래되고 단백뇨 및 FSGS와 같은 신병증이 발현될 수 있으므로 비만에 대한 적절한 관리와 치료가 필요할 것으로 생각된다.

Keywords

References

  1. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity : public-health crisis, common sense cure. Lancet 2002;360: 473-82 https://doi.org/10.1016/S0140-6736(02)09678-2
  2. Dietz WH. Health consequences of obesity in youth : childhood predictors of adult disease. Pediatrics 1998;101:518-25
  3. Adelman RD. Obesity and renal disease. Curr Opin Nephrol Hypertens 2002;11:331-335 https://doi.org/10.1097/00041552-200205000-00010
  4. Park YS, Lee DH, Choi JM, Kang YJ, Kim CH. Trend of obesity in school age children in seoul over the past 23 years. Korean J Pediatr 2004;47:247-57
  5. Kim EY, Rho YI, Yang ES, Park SK, Park YB, Moon KR, et al. Six year follow-up of childhood obesity. Korean J Pediatr 2001;44:1295-300
  6. Adelman RD, Restaino IG, Alon US, Blowey DL. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001;138:481-5 https://doi.org/10.1067/mpd.2001.113006
  7. Praga M, Hernandez E, Andres A, Leon M, Ruilope LM, Rodicio JL. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995; 70:35-41 https://doi.org/10.1159/000188541
  8. Praga M, Morales E, Herrero JC, Perez Campos A, Dominguez- Gil B, Alegre R, et al. Absense of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am J Kidney Dis 1999;33:52-8. https://doi.org/10.1016/S0272-6386(99)70257-X
  9. Zucchelli P, Cagnoli L, Casanova S, Donini U, Pasquali S. Focal glomerulosclerosis in patients with unilateral nephrectomy. Kidney Int 1983;24:649-55 https://doi.org/10.1038/ki.1983.207
  10. Gutierrez-Millet V, Nieto J, Praga M, Usera G, Martinez MA, Morales JM. Focal glomerulosclerosis and proteinuria in patients with solitary kidneys. Arch Intern Med 1986; 146:705-9 https://doi.org/10.1001/archinte.146.4.705
  11. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000;278:F817-22 https://doi.org/10.1152/ajprenal.2000.278.5.F817
  12. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome : a complication of massive obesity. Ann Intern Med 1974;81:440-7 https://doi.org/10.7326/0003-4819-81-4-440
  13. Jennette JC, Charles L, Grubb W. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am J Kidney Dis 1987;10:470- 2
  14. Faustinella F, Uzoh C, Sheikh-Hamad D, Truong LD, Olivero JJ. Glomerulomegaly and proteinuria in a patient with idiopathic pulmonary hypertension. J Am Soc Nephrol 1997; 8:1966-70
  15. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy : an emerging epidemic. Kidney Int 2001;59:1498-509 https://doi.org/10.1046/j.1523-1755.2001.0590041498.x
  16. Fogo A, Ichikawa I. Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis 1991;17:666-9 https://doi.org/10.1016/S0272-6386(12)80347-7
  17. Shimamura T. Focal glomerulosclerosis in obese Zucker rats and prevention of its development. Kidney Int Suppl 1983;16:S259-62
  18. Verani RR. Obesity-associated focal segmental glomerulosclerosis : pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 1992;20:629-34 https://doi.org/10.1016/S0272-6386(12)70230-5
  19. Noda M, Matsuo T, Nagano-Tsuge H, Ohta M, Sekiguchi M, Shibouta Y, et al. Involvement of angiotensin II in progression of renal injury in rats with genetic non-insulindependent diabetes mellitus(Wistar fatty rats). Jpn J Pharmacol 2001;85:416-22 https://doi.org/10.1254/jjp.85.416
  20. Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 1996;28:127-32 https://doi.org/10.1161/01.HYP.28.1.127
  21. Fujiwara K, Hayashi K, Ozawa Y, Tokuyama H, Nakamura A, Saruta T. Renal protective effect of troglitazone in Wistar fatty rats. Metabolism 2000;49:1361-4 https://doi.org/10.1053/meta.2000.9509
  22. Anderson PW, Zhang XY, Tian J, Correale JD, Xi XP, Yang D, et al. Insulin and angiotension II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. Kidney Int 1996;50:745-53 https://doi.org/10.1038/ki.1996.372
  23. Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, et al. Leptin stimulates proliferation and TGFbeta expression in renal glomerular endothelial cells : potential role in glomerulosclerosis. Kidney Int 1999;56:860-72 https://doi.org/10.1046/j.1523-1755.1999.00626.x
  24. Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, et al. Leptin stimulates type I collagen production in db/ db mesangial cells : glucose uptake and TGF-beta type II receptor expression. Kidney Int 2001;59:1315-23 https://doi.org/10.1046/j.1523-1755.2001.0590041315.x
  25. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000;97: 8015-20 https://doi.org/10.1073/pnas.120055097
  26. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000;11:25-38
  27. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988;33:667-72. https://doi.org/10.1038/ki.1988.51
  28. Newman DJ. Cystatin C. Ann Clin Biochem 2002;39:89-104 https://doi.org/10.1258/0004563021901847
  29. Wong H, Vivian L, Weiler G, Filler G. Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis 2004;43:624-8 https://doi.org/10.1053/j.ajkd.2003.12.026